Middle East and Africa
| AstraZeneca Solid Forms Production Plant, Cairo | ||
AstraZeneca is building a pharmaceutical solid forms production facility in Sixth of October City (Madinat Sittah Uktubar) near Cairo. |
The pharmaceutical production facility will produce tablets and capsules. |
The new production plant will produce a broad range of the company's product portfolio including cardiovascular, psychiatric and cancer treatments. |
| Cipra Medpro Ltd, Durban | ||
The Enaleni Pharmaceuticals manufacturing plant is in Durban, South Africa. |
Enaleni Pharmaceuticals is now South Africa's sixth-largest pharma company. |
Enaleni's new headquarters is in Cape Town, as of January 2008. |
Enaleni also manufactures generics such as aspirin for other companies under contract. |
Enaleni hopes to obtain part of the HIV drug contract for South Africa. |
|
| DuBiotech, | ||
The double-tower HQ building of the Dubiotech complex was completed ahead of schedule. |
The Nucleotide Complex lab building has begun operations. |
The DuBiotech complex will eventually occupy an area of around 30,000,000ft². |
The Nucleotide building has four wings: A, T, C and G, named after the DNA nucleotide bases. |
The HQ building architecture is based on an agar gel electrophoresis plate analysing DNA fragments. |
The first phase of the DuBiotech park has attracted over DH1.2bn in investment. |
| Neopharma Pharmaceutical | ||
Example of the pharmaceuticals to be produced at the NeoPharma facility. |
A generic structure of cephalosporin and penicillin. |
NeoPharma aims to produce 45 million units of antibiotics in its first year. |
In July 2003 NeoPharma opened a new pharmaceutical plant in Abu Dhabi, United Arab Emirates. |
Neopharma has vastly increased its range of products since 2003. |
One of the newest products is a version of Metformin for treatment of type 2 diabetes and PCOS (polycystic ovary syndrome). |
| Quality Chemical Industries, | ||
The HIV drug plant will produce 600 million tablets per year. |
The Quality Chemical Industries facility will employ 500 personnel in both production and R&D. |
The two therapies produced will be ARVs and first-line antimalarials. |
The new $38m facility in Kampala. |
The inauguration of the plant was undertaken by President Yoweri Museveni of Uganda. |
Uganda has made an enormous effort to defeat HIV. |
| Roche Vitamins and Minerals Premix Plant, | ||
Roche vitamins and minerals premix plant in Isando, South Africa. |
The facility manufactures vitamin premixes for the food and pharmaceutical industry in South Africa and surrounding African nations. |
Rovimix Vitamin B2 being packed. |
Roche is the leading supplier of vitamins and carotenoids, the latter seen here in production. |
Astaxanthin production; the plant at Isando can now produce the necessary vitamin and mineral premixes to supplement basic foodstuffs. |
Vitromix packaging; Roche has a total of 48 premix facilities around the world. |
| SAJAPHCO Pharmaceuticals Formulation Plant, | ||
Location of SAJAPHCO´s new pharmaceuticals formulation plant in Jeddah, Saudi Arabia. |
The plant was completed in 2002 and produces formulations for Sankyo and Yamanouchi. |
The plant in the final stages of construction; trial formulation began in August 1999. |
Plant under construction in 1998; contractors were JGC (Arabia) and FREYSSINET SAUDI ARABIA CO. LTD. |
Foundations and initial stages of plant construction. |
|
